Business Context and Reporting Period
Company: Playboy, Inc. (PLBY)
Filing Type: Form 8-K (Current Report)
Date of Report: December 15, 2025
Reporting Period: Immediate event reporting regarding corporate governance changes.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing compliance matters.
Material Changes
- Director Resignation: Natalia Premovic resigned from the Board of Directors effective December 15, 2025, citing personal reasons. The resignation is not related to any disagreement with the Company regarding operations, policies, or practices.
- Board Composition: Following the resignation, the Board consists of three independent directors, three non-independent directors, and one vacant seat.
- Nasdaq Non-Compliance: The Company notified Nasdaq on December 16, 2025, of temporary noncompliance with Listing Rule 5605(b) regarding the requirement for a majority of independent directors. A deficiency letter was received on December 18, 2025.
Outlook, Risks, and Management Commentary
- Cure Period: The Company is utilizing the cure period under Nasdaq Listing Rule 5605(b)(1)(A), which is expected to expire on the date of the 2026 annual meeting of stockholders.
- Remediation Plan: The Company is actively identifying a new independent director to fill the vacancy and anticipates appointing a replacement within the applicable cure period.
- Committee Status: All Board committees remain composed solely of independent directors as Ms. Premovic was not a member of any committee.
- Trading Status: The noncompliance has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Global Market.
Investor Verification Checklist
- Confirm the timeline for the appointment of a new independent director to ensure compliance before the 2026 annual meeting.
- Monitor future 8-K filings for the official announcement of the new director's appointment.
- Verify that the Board's committee structures remain fully independent during the vacancy period.
- Review the Company's proxy statement for the 2026 annual meeting to confirm the final Board composition.